Logo image of IH

IHUMAN INC (IH) Stock Fundamental Analysis

NYSE:IH - New York Stock Exchange, Inc. - US45175B1098 - ADR - Currency: USD

3.07  +0.2 (+6.97%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to IH. IH was compared to 72 industry peers in the Entertainment industry. IH gets an excellent profitability rating and is at the same time showing great financial health properties. IH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

IH had positive earnings in the past year.
IH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IH reported negative net income in multiple years.
IH had a positive operating cash flow in each of the past 5 years.
IH Yearly Net Income VS EBIT VS OCF VS FCFIH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

The Return On Assets of IH (6.90%) is better than 86.11% of its industry peers.
IH's Return On Equity of 10.20% is amongst the best of the industry. IH outperforms 81.94% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.61%, IH is in the better half of the industry, outperforming 76.39% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IH is significantly below the industry average of 23.15%.
The 3 year average ROIC (11.46%) for IH is well above the current ROIC(6.61%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.9%
ROE 10.2%
ROIC 6.61%
ROA(3y)9.23%
ROA(5y)3.94%
ROE(3y)14.49%
ROE(5y)5.97%
ROIC(3y)11.46%
ROIC(5y)N/A
IH Yearly ROA, ROE, ROICIH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

Looking at the Profit Margin, with a value of 10.63%, IH belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
The Operating Margin of IH (7.81%) is better than 73.61% of its industry peers.
With an excellent Gross Margin value of 69.41%, IH belongs to the best of the industry, outperforming 81.94% of the companies in the same industry.
IH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.81%
PM (TTM) 10.63%
GM 69.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y2.45%
IH Yearly Profit, Operating, Gross MarginsIH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

IH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, IH has less shares outstanding
The number of shares outstanding for IH has been increased compared to 5 years ago.
IH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IH Yearly Shares OutstandingIH Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IH Yearly Total Debt VS Total AssetsIH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 2.94 indicates that IH is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of IH (2.94) is better than 76.39% of its industry peers.
IH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.94
ROIC/WACC0.88
WACC7.54%
IH Yearly LT Debt VS Equity VS FCFIH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.98 indicates that IH has no problem at all paying its short term obligations.
IH has a better Current ratio (2.98) than 86.11% of its industry peers.
IH has a Quick Ratio of 2.93. This indicates that IH is financially healthy and has no problem in meeting its short term obligations.
IH has a Quick ratio of 2.93. This is amongst the best in the industry. IH outperforms 86.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.93
IH Yearly Current Assets VS Current LiabilitesIH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for IH have decreased strongly by -46.24% in the last year.
The Revenue has decreased by -9.40% in the past year.
IH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.34% yearly.
EPS 1Y (TTM)-46.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.08%
Revenue 1Y (TTM)-9.4%
Revenue growth 3Y-0.81%
Revenue growth 5Y33.34%
Sales Q2Q%-6.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IH Yearly Revenue VS EstimatesIH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IH Yearly EPS VS EstimatesIH Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 1 -1 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.81 indicates a reasonable valuation of IH.
IH's Price/Earnings ratio is rather cheap when compared to the industry. IH is cheaper than 90.28% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.91. IH is valued rather cheaply when compared to this.
IH is valuated reasonably with a Price/Forward Earnings ratio of 10.71.
Based on the Price/Forward Earnings ratio, IH is valued cheaper than 91.67% of the companies in the same industry.
IH is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.81
Fwd PE 10.71
IH Price Earnings VS Forward Price EarningsIH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

IH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IH is cheaper than 76.39% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IH is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.31
EV/EBITDA 12.5
IH Per share dataIH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of IH may justify a higher PE ratio.
PEG (NY)1.88
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

IH has a Yearly Dividend Yield of 2.47%. Purely for dividend investing, there may be better candidates out there.
IH's Dividend Yield is rather good when compared to the industry average which is at 6.03. IH pays more dividend than 93.06% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, IH has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.47%

5.2 History

IH is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
IH Yearly Dividends per shareIH Yearly Dividends per shareYearly Dividends per share 2024 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

35.71% of the earnings are spent on dividend by IH. This is a low number and sustainable payout ratio.
DP35.71%
EPS Next 2YN/A
EPS Next 3YN/A
IH Yearly Income VS Free CF VS DividendIH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M
IH Dividend Payout.IH Dividend Payout, showing the Payout Ratio.IH Dividend Payout.PayoutRetained Earnings

IHUMAN INC

NYSE:IH (7/29/2025, 8:04:00 PM)

3.07

+0.2 (+6.97%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)06-26 2025-06-26
Earnings (Next)09-26 2025-09-26
Inst Owners1.11%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap160.32M
Analysts86.67
Price TargetN/A
Short Float %0.04%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield 2.47%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP35.71%
Div Incr Years0
Div Non Decr Years1
Ex-Date04-17 2025-04-17 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.81
Fwd PE 10.71
P/S 1.25
P/FCF 22.31
P/OCF 19.49
P/B 1.2
P/tB 1.22
EV/EBITDA 12.5
EPS(TTM)0.26
EY8.47%
EPS(NY)0.29
Fwd EY9.34%
FCF(TTM)0.14
FCFY4.48%
OCF(TTM)0.16
OCFY5.13%
SpS2.46
BVpS2.57
TBVpS2.52
PEG (NY)1.88
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.9%
ROE 10.2%
ROCE 7.41%
ROIC 6.61%
ROICexc 6.61%
ROICexgc 6.72%
OM 7.81%
PM (TTM) 10.63%
GM 69.41%
FCFM 5.59%
ROA(3y)9.23%
ROA(5y)3.94%
ROE(3y)14.49%
ROE(5y)5.97%
ROIC(3y)11.46%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.85%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y2.45%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 53.21%
Cap/Sales 0.81%
Interest Coverage 250
Cash Conversion 68.6%
Profit Quality 52.6%
Current Ratio 2.98
Quick Ratio 2.93
Altman-Z 2.94
F-Score5
WACC7.54%
ROIC/WACC0.88
Cap/Depr(3y)56.19%
Cap/Depr(5y)248.22%
Cap/Sales(3y)0.71%
Cap/Sales(5y)1.71%
Profit Quality(3y)103.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.08%
EPS Next Y6.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.4%
Revenue growth 3Y-0.81%
Revenue growth 5Y33.34%
Sales Q2Q%-6.8%
Revenue Next Year8.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.85%
FCF growth 3Y105.96%
FCF growth 5Y5.1%
OCF growth 1Y-65.7%
OCF growth 3Y15.59%
OCF growth 5Y6.73%